SLU-PP-332

🔹 What is SLU-PP-332?

Class: Synthetic small-molecule peptide analog; potent pan-agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ). Mechanism:

• Activates ERRα (EC₅₀ ≈ 98 nM), ERRβ (EC₅₀ ≈ 230 nM), and ERRγ (EC₅₀ ≈ 430 nM), with highest potency for ERRα.
• Enhances mitochondrial function and cellular respiration in skeletal muscle cell lines.
• Increases fast oxidative skeletal muscle fibers (Type IIa) and exercise endurance in mice in an ERRα-specific manner.
• Activates an acute aerobic exercise genetic response via inducing the expression of DDIT4.
• Mimics key effects of endurance exercise, such as enhanced energy metabolism, mitochondrial biogenesis, and fat oxidation, without influencing estrogen receptor pathways.

Primary focus:

• Metabolic enhancement and fat loss.
• Mitochondrial biogenesis and muscle endurance.
• Exercise mimetic effects without the need for physical activity.
• Potential applications in metabolic disorders and anti-aging.

---

🔹 Oral Dosage

• Available in capsule form for ease of administration.
• Range studied/used in research: Limited to preclinical animal work; human data are sparse. Oral bioavailability is reported but variable. Typical protocol: Anecdotal human use ranges from 5–20 mg once daily, often split into two doses (morning + pre-workout). Clinical standards are not yet established.
• Many biohacking communities dose in mcg, taking 500-5000mcg twice daily. Notes: Take on an empty stomach for best absorption; absorption may vary widely between formulations.

---

🔹 Injectable / Subcutaneous Dosage (most common)

• Range: Preclinical models use ~0.1–1.0 mg/kg per day; no formal human injectable guidelines. Anecdotal protocols recommend 0.5–1.0 mg SC daily. Frequency: Once daily, ideally timed around exercise or in the morning to synergize with circadian metabolism. Rationale: Direct SC dosing bypasses first-pass metabolism, ensuring more consistent receptor engagement and predictable metabolic effects

---

🔹 Cycle Length

• Research protocols vary; typical cycles range from 4 to 12 weeks, depending on study design and objectives.

---

🔹 Optimal Dosing Window

• Oral/Sublingual: Morning on an empty stomach, and again 30 minutes before workouts to maximize pre-exercise energy signaling.
• Injectable: First thing in the morning or 30–60 minutes pre-workout for peak receptor activation during activity.

---

✅ Educational Integration Example Example protocol: 1 mg oral capsule daily for 8 weeks. Paired with: Lifestyle modifications, including dietary adjustments and physical activity. Rationale: Supports fat loss, metabolic health, and muscle endurance through exercise-mimetic effects.

---

🔹 Stacking Strategy (Educational / Complementary) Since SLU-PP-332 primarily targets ERRα, ERRβ, and ERRγ, stacking strategies focus on enhancing mitochondrial function, fat metabolism, and muscle endurance: 🔸 Metabolic & Fat Loss Support

• 5-Amino-1MQ: Targets fat metabolism and energy balance.
• BPC-157: Supports muscle recovery and tissue repair.

🔸 Mitochondrial & Endurance Support

• BAM-15: Enhances fat oxidation without stimulating the central nervous system.
• L-Carnitine: Facilitates fatty acid transport into mitochondria for energy production.

Rationale: Combining SLU-PP-332 with complementary agents can enhance fat loss, muscle endurance, and metabolic health.

---

⚠️ Safety Notes

• Gastrointestinal side effects (e.g., nausea, diarrhea) are common, especially during dose escalation.
• Contraindicated in individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
• Not intended for human or animal use; for research purposes only.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.